nach oben

International Urogynecology Journal

Erschienen in:

01.04.2010 | Original Article

Do women with overactive bladder have realistic expectations for therapy?

verfasst von: Arasee Renganathan, Dudley Robinson, Linda Cardozo, Sushma Srikrishna, Rufus Cartwright

Erschienen in: International Urogynecology Journal | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

This study aims to determine what women with overactive bladder (OAB) perceive as ‘cure’, assesses treatment acceptability and adverse events. It also determines impact on quality of life (QoL) and correlates it with expectations from therapy.

Methods

In 153 women with predominant OAB symptoms, QoL and expectations regarding ‘cure’ were assessed using KHQ and a novel questionnaire. Analyses were performed using Pearson’s correlation and ANOVA.

Results

Conservative measures and lifestyle modifications were acceptable whilst urge incontinence, coital incontinence, constant pad and medication usage were unpopular. Overall, 65% expected to stop leaking altogether once treated. Older women were less prepared to accept side effects such as constipation (p = 0.03) and dry mouth (p = 0.012). ANOVA showed significant difference between mean QoL scores for women with different expectations of cure (p = 0.049).

Conclusions

Majority of women have realistic expectations regarding treatment and are willing to tolerate minor symptoms. Regular antimuscarinics remain unpopular and may explain low persistence.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) Standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Am J Obstet Gynecol 187(1):116–126CrossRefPubMed

Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L (2006) Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 97(1):96–100CrossRefPubMed

Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P (1993) The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 22(2):82–89CrossRefPubMed

Simeonova Z, Milsom I, Kullendorff AM, Molander U, Bengtsson C (1999) The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population. Acta Obstet Gynecol Scand 78(6):546–551CrossRefPubMed

Robinson D, Anders K, Cardozo L, Bidmead J, Dixon A, Balmforth J et al (2003) What do women want? Interpretation of the concept of cure. J Pelvic Med Surg 9:273–277CrossRef

Burgio KL, Nygaard IE, Richter HE, Brubaker L, Gutman RE, Leng W et al (2007) Pelvic Floor Disorders Network. Bladder symptoms 1 year after abdominal sacrocolpopexy with and without Burch colposuspension in women without preoperative stress incontinence symptoms. Am J Obstet Gynecol 197(6):647CrossRefPubMed

Brubaker L, Shull BL (2005) EGGS for patient centered outcomes. Int Urogynecol J 16:171–173CrossRef

Srikrishna S, Robinson D, Cardozo L, Cartwright R (2008) Experiences and expectations of women with urogenital prolapse: a quantitative and qualitative exploration. BJOG 115(11):1362–1368CrossRefPubMed

Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMed

10.

Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 104(9):988–993PubMed

11.

Pelletier EM, Vats V, Clemens JQ (2009) Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. Am J Manag Care 15(4 Suppl):S108–114PubMed

12.

Chapple CR, Artibani W, Cardozo LD, Castro-Diaz D, Craggs M, Haab F et al (2005) The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int 95(3):335–340CrossRefPubMed

13.

Abrams P (2005) Urgency: the key to defining the overactive bladder. BJU Int 96(Suppl 1):1–3CrossRefPubMed

14.

Coyne KS, Payne C, Bhattacharyya SK, Revicki DA, Thompson C, Corey R et al (2004) The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health 7(4):455–463CrossRefPubMed

15.

Artibani W (2007) Outcomes in overactive bladder treatment: patient perception—a key to success. Eur Urol Suppl 6:17–22CrossRef

16.

Cardozo L, Hessdörfer E, Milani R, Arañó P, Dewilde L, Slack M et al (2008) SUNRISE Study Group. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial. BJU Int 102(9):1120–1127CrossRefPubMed

17.

http://www.nice.org.uk/nicemedia/pdf/CG40fullguideline.pdf (last accessed 08.08.09)

18.

Hannestad YS, Rortveit G, Daltveit AK et al (2003) Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 110(3):247–254CrossRefPubMed

19.

Arya LA, Myers DL, Jackson ND (2000) Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol 96(1):85–89CrossRefPubMed

20.

Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z (2005) Persistence with overactive bladder pharmacotherapy in a Medicaid population. Am J Manag Care 11(4 Suppl):S121–129PubMed

21.

Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP (2005) Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 19(8):607–613CrossRefPubMed

22.

Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C et al (2005) Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol 61(9):667–674CrossRefPubMed

23.

Burton G (1994) A randomised crossover trial comparing oxybutynin taken three times a day or taken ‘when needed’. Neurourol Urodyn 13:351–352

24.

Stevenson JC (1999) Optimising delivery systems for HRT. Maturitas 33(Suppl 1):S31–38CrossRefPubMed

25.

http://www.bladderandbowelfoundation.org/policy/making-the-case-for-investment-in-an-integrated-continence-service/the-cost-of-incontinence-to-the-nhs.htm

26.

Johannesson M, O’Conor RM, Kobelt-Nguyen G, Mattiasson A (1997) Willingness to pay for reduced incontinence symptoms. Br J Urol 80:557–562PubMed

Titel: Do women with overactive bladder have realistic expectations for therapy?
verfasst von: Arasee Renganathan
Dudley Robinson
Linda Cardozo
Sushma Srikrishna
Rufus Cartwright
Publikationsdatum: 01.04.2010
Verlag: Springer-Verlag
Erschienen in: International Urogynecology Journal / Ausgabe 4/2010
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-009-1049-9

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Do women with overactive bladder have realistic expectations for therapy?

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Factors involved in stress urinary incontinence 1 year after first delivery

Long-term results of vaginal repairs with and without xenograft reinforcement

Perineal leiomyoma mimicking complex Bartholin mass

Complete bladder eversion concurrent with total uterine prolapse

Cyclical estrogen and free radical damage to the rabbit urinary bladder

A 31-year-old woman with urethral duplication, stress urinary incontinence, uterovaginal prolapse, and rectal prolapse

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie